Lara Nonell Selected Research

Lara Nonell Research Topics

Disease

12	Neoplasms (Cancer) 10/2022 - 11/2012
2	COVID-19 05/2023 - 01/2022
2	Melanoma (Melanoma, Malignant) 01/2023 - 04/2015
2	Lymphocytosis 10/2021 - 02/2014
2	Inflammation (Inflammations) 01/2021 - 11/2015
2	Myocardial Infarction 01/2021 - 01/2020
2	Multiple Sclerosis 01/2011 - 02/2009
1	Critical Illness (Critically Ill) 10/2023
1	Triple Negative Breast Neoplasms 01/2023
1	Acidosis 01/2023
1	Disease Progression 01/2023
1	Chronic Urticaria 11/2022
1	Neuroinflammatory Diseases 02/2022
1	Chronic Disease (Chronic Diseases) 02/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Carcinoma (Carcinomatosis) 12/2021
1	Barrett Esophagus (Barrett's Esophagus) 07/2021
1	Adenocarcinoma 07/2021
1	Infections 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Actinic Keratosis 01/2020
1	Atherosclerosis 01/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019
1	Chromosome Aberrations (Chromosome Abnormalities) 12/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2017
1	Necrosis 10/2016
1	Fibrosis (Cirrhosis) 10/2016
1	Neoplasm Metastasis (Metastasis) 12/2015
1	Breast Neoplasms (Breast Cancer) 12/2015
1	Weight Loss (Weight Reduction) 11/2015
1	Colorectal Neoplasms (Colorectal Cancer) 04/2015
1	Primary Cutaneous Anaplastic Large Cell Lymphoma 04/2015
1	Mycosis Fungoides 04/2015
1	Skin Diseases (Skin Disease) 04/2015
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 04/2015
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2014

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2011
5	MicroRNAs (MicroRNA)IBA 01/2022 - 04/2015
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2009
3	RNA (Ribonucleic Acid)IBA 05/2023 - 12/2017
3	Messenger RNA (mRNA)IBA 07/2021 - 11/2012
1	STAT5 Transcription FactorIBA 10/2023
1	NF-kappa B (NF-kB)IBA 10/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2023
1	Interferon-gamma (Interferon, gamma)IBA 10/2023
1	Interleukin-2 (IL2)IBA 10/2023
1	Receptor for Advanced Glycation End ProductsIBA 01/2023
1	LigandsIBA 01/2023
1	Platelet Activating FactorIBA 11/2022
1	Cholecystokinin (Pancreozymin)IBA 02/2022
1	GastrinsIBA 02/2022
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 02/2022
1	Circulating MicroRNAIBA 01/2022
1	vinflunineIBA 12/2021
1	PlatinumIBA 12/2021
1	HLA-G Antigens (HLA G)IBA 10/2021
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2021
1	A-factor (Streptomyces)IBA 01/2021
1	3-ingenyl angelateIBA 01/2020
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020
1	Choline KinaseIBA 01/2020
1	CytokinesIBA 01/2019
1	IpilimumabIBA 01/2019
1	Vitamin D FDA LinkGeneric 11/2017
1	Temozolomide (Temodar)FDA LinkGeneric 10/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2016
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2016
1	Maf Transcription FactorsIBA 12/2015
1	Parathyroid Hormone-Related ProteinIBA 12/2015
1	Serine (L-Serine)FDA Link 04/2015
1	Phosphotransferases (Kinase)IBA 04/2015
1	Co-Repressor ProteinsIBA 04/2015
1	Cyclin D1IBA 02/2014
1	CyclinsIBA 02/2014
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 02/2014
1	TensinsIBA 02/2014
1	Peptides (Polypeptides)IBA 02/2014
1	Ceruloplasmin (Ferroxidase)IBA 02/2014
1	betaglycan (TGFBR3)IBA 02/2014
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 02/2014
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2014
1	Antiviral Agents (Antivirals)IBA 01/2011
1	Interferon-betaIBA 02/2009
1	Matrix Metalloproteinases (MMPs)IBA 02/2009

Therapy/Procedure

5	Therapeutics 01/2023 - 02/2009
2	Immunotherapy 10/2022 - 01/2019
2	Drug Therapy (Chemotherapy) 12/2021 - 10/2016
2	Aftercare (After-Treatment) 01/2020 - 10/2016
1	Mediterranean Diet 02/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2022